Related Experiment Video
Updated: Jan 21, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Multimodality imaging of naturally active melanin nanoparticles targeting somatostatin receptor subtype 2 in human
Lei Xia1, Xiaoyi Guo, Teli Liu
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China. zhuhuananjing@163.com pekyz@163.com.
Abstract:
Somatostatin receptor subtype 2 (SSTR2) is highly expressed in pulmonary neuroendocrine tumors, which account for approximately 25% of all lung cancers including small-cell lung cancer (SCLC). It is possible to establish SCLC-specific imaging agents for multimodal imaging to obtain tumor integrity information. Herein, we constructed novel multifunctional organic melanin nanoparticles (MNPs) as a carrier and surface-loaded somatostatin analog octreotide to produce a human small-cell lung cancer-targeted nanoprobe OCT-PEG-MNPs. MNPs have an excellent photoacoustic imaging (PAI) function and can be directly chelated with the magnetic resonance contrast agent Mn2+, and N-bromo succinimide (NBS) can be used as an oxidant to label the nanoparticles with the long half-life radionuclide 124I by an electrophilic substitution reaction. Therefore, (124I, Mn) OCT-PEG-MNPs can not only be used for PAI but also be used for positron emission tomography (PET) and magnetic resonance imaging (MRI). The NCI-H69 SCLC tumor xenograft model with high SSTR2 expression was constructed to evaluate the multimodal imaging ability of (124I, Mn) OCT-PEG-MNPs. This nanoprobe showed good imaging abilities in PAI, MRI and PET. The PA images showed that the photoacoustic signal in the NCI-H69 tumor site gradually increased with time, and the NCI-H69 xenograft showed a clear increase in the T1-weighted signal intensity after injection of Mn-OCT-PEG-MNPs at 24 h compared to that in the prescan. MicroPET and biodistribution studies showed that the uptake of NCI-H69 tumors (8.03 ± 0.37% ID g-1) was significantly higher than that in the control A549 model (3.35 ± 0.54% ID g-1) after injection of (124I, Mn) OCT-PEG-MNPs at 24 h. The (124I, Mn) OCT-PEG-MNPs were successfully applied to multimodal imaging in a small-cell lung cancer model with high SSTR2 expression. This nanoprobe may be considered for clinical trials since it combines the numerous advantages of organic nanoparticles.
Insights
Researchers developed a novel nanoprobe for multimodal imaging of small-cell lung cancer (SCLC). This probe targets SCLC tumors expressing somatostatin receptor subtype 2 (SSTR2), enabling enhanced detection via photoacoustic imaging, MRI, and PET scans.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Pulmonary neuroendocrine tumors, including small-cell lung cancer (SCLC), represent a significant portion of lung cancer cases.
- Somatostatin receptor subtype 2 (SSTR2) is highly expressed in SCLC, making it a potential therapeutic and diagnostic target.
- Multimodal imaging agents are needed to provide comprehensive tumor integrity information for SCLC.
Purpose of the Study:
- To construct a novel multifunctional nanoprobe for targeted multimodal imaging of SCLC.
- To evaluate the efficacy of the developed nanoprobe in a preclinical SCLC model.
Main Methods:
- Organic melanin nanoparticles (MNPs) were synthesized and surface-functionalized with octreotide, a somatostatin analog, creating OCT-PEG-MNPs.
- MNPs were labeled with manganese (Mn2+) for magnetic resonance imaging (MRI) and iodine-124 (124I) for positron emission tomography (PET).
- The multimodal imaging capabilities of the (124I, Mn) OCT-PEG-MNPs were assessed in an NCI-H69 SCLC tumor xenograft model with high SSTR2 expression.
Main Results:
- The (124I, Mn) OCT-PEG-MNPs demonstrated effective multimodal imaging performance in photoacoustic imaging (PAI), MRI, and PET.
- PAI showed increasing signal in the tumor site over time.
- MRI revealed enhanced T1-weighted signal intensity in the xenograft 24 hours post-injection.
- PET and biodistribution studies indicated significantly higher uptake in SCLC tumors compared to control models.
Conclusions:
- The developed (124I, Mn) OCT-PEG-MNPs are effective for multimodal imaging of SCLC with high SSTR2 expression.
- This nanoprobe integrates PAI, MRI, and PET capabilities, offering a promising tool for SCLC diagnosis and management.
- The organic nanoparticle-based nanoprobe shows potential for future clinical translation.
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Nature and Nurture
Internal Receptors
What is Natural Selection?

